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Summary
Objective: The collagen network in human articular cartilage experiences a large number of stress cycles during life as it shows hardly any
turnover after adolescence. We hypothesized that, to withstand fatigue failure, the physical condition of the collagen network laid down at
adolescence is of crucial importance for the age of onset of osteoarthritis (OA).
Methods: We have compared the lysyl hydroxylation level and pyridinoline cross-link level of the collagen network of degenerated (DG)
cartilage of the femoral knee condyle (representing a preclinical early stage of OA) with that of normal cartilage from the contralateral knee.
The biological age of the collagen network was determined by means of pentosidine levels. For each donor, collagen modiÞcations of normal
cartilage were compared with DG cartilage that showed no signiÞcant remodeling of the collagen network (as evidenced by identical
pentosidine levels).
Results: DG cartilage contained signiÞcantly more hydroxylysine residues per collagen molecule in comparison with healthy cartilage from
the same donor, both in the upper and lower half (the region near the articular surface and adjacent to bone, respectively). In addition, a
signiÞcantly higher level of pyridinoline cross-linking was observed in the upper half of DG cartilage. Considering the biological age of the
collagen network, the changes observed in DG cartilage must have been present several decades before cartilage became degenerated.
Conclusions: The data suggest that high levels of lysyl hydroxylation and pyridinoline cross-linking result in a collagen network that fails
mechanically in long term loading. Areas containing collagen with low hydroxylysine and pyridinoline levels are less prone to degeneration.
As such, this study indicates that post-translational modiÞcations of collagen molecules synthesized during adolescence are causally
involved in the pathogenesis of OA. © 2002 OsteoArthritis Research Society International
Key words: Osteoarthritis, Collagen, Hydroxylysine, Pyridinoline, Fatigue.Received 7 September 2000; revision requested 27 October
2000; revision received 7 March 2001; accepted 20 August 2001.
Supported by a grant of The Dutch Arthritis Association.
Address correspondence to: Dr Ruud A. Bank, Ph.D., TNO
Prevention and Health, Division of Vascular and Connective Tissue
Research, P.O. Box 2215, 2301 CE Leiden, The Netherlands. Tel:
#31-71-5181503; Fax: #31-71-5181904; E-mail: RA.Bank@
pg.tno.nlIntroduction
The extracellular matrix of cartilage is essentially a Þber-
reinforced gel, containing highly negatively charged
proteoglycans entangled in a network of collagen Þbrils.
Because of their intrinsic property to attract water, proteo-
glycans have a tendency to swell. The tensile stiffness of
the collagen network counteracts this swelling. It is this
delicate balance that endows cartilage with its load-bearing
properties12. As a consequence of the swelling properties
of proteoglycans, collagen is under constant tension, even
when cartilage is unloaded. When loaded, e.g. during
standing or walking, joint cartilage undergoes high com-
pressive forces, ranging from 40 to 200 atmospheres3.
Loading is accompanied by a displacement of proteogly-
cans; this bulk movement of the proteoglycanwater gel is127resisted by the collagen network4. By doing so, the colla-
gen network must experience increased tensile stresses.
Especially under cyclic loading, such as in walking, the
collagen network is continuously exposed to stress cycles.
The collagen network of articular cartilage consists of
several collagen types, namely collagen type II, IX and XI5.
One of the earliest changes seen in osteoarthritis (OA) is
an increase in water content in articular cartilage6. This is
due to a damaged collagen network, resulting in a loss of
tensile stiffness68. Several decades ago, Freeman sug-
gested that the primary event in the pathogenesis of
idiopathic (primary) OA is a collagen fatigue failure9.
Fatigue refers to the failure of a material because of
repetitive stressing at a level below the ultimate strength of
the material. The fatigue theory has been investigated in
detail by Weightman1012. An important feature of the
collagen network in adult human articular cartilage is that it
hardly shows turnover1314. Thus, the collagen network
experiences a large number of stress cycles during life. We
hypothesize, therefore, that to withstand fatigue the physi-
cal condition of the collagen network laid down at adoles-
cence is of crucial importance to the age of onset of OA.
An implication of the above hypothesis is that a qualita-
tively inferior collagen network results in early-onset OA.
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and XI in hereditary osteochondrodysplasias (such as
spondyloepiphyseal dysplasia, Marshall and Stickler syn-
drome) that are associated with severe and early-onset
OA1520. More interestingly, two recurrent point mutations
(Arg75→Cys and Arg519→Cys) and a reduced expression
of collagen type II have been found in patients with early-
onset, primary, generalized OA17,2131. In these cases, the
development of OA does not involve anatomic abnormali-
ties, and is primarily due to an impaired collagen network.
As a matter of fact, the role of collagen mutations in the
development of OA has been conÞrmed in transgenic mice
studies3236, once more highlighting the important role of a
reduction of collagen Þbril quality in the pathogenesis of
early-onset OA.
It has been found that the Arg519→Cys mutation in the
1(II) chain results in an increased level of triple helical
lysyl hydroxylation of collagen type II22. A higher lysyl
hydroxylation level of collagen has been found in a variety
of pathological conditions, such as osteogenesis imper-
fecta, osteoporosis, and osteochondrodysplasias3739. A
relationship has been established between overmodiÞ-
cation and phenotypic severity of the disease: the higher
the level of lysyl hydroxylation, the more severe the pheno-
type39. A higher lysyl hydroxylation level is not always the
result of collagen mutations, but can also be due to e.g.
increased levels of lysyl hydroxylase4041. We hypothesize
that an increase in lysyl hydroxylation of the triple helix
results in subtle changes of the collagen network, giving
rise to a qualitatively inferior network. If so, lysyl hydroxyl-
ation might play a role in the age of onset of OA: a collagen
network with high hydroxylysine levels might be more
prone to fatigue.
Macroscopically Þbrillated cartilage is frequently
observed in the knees of donors without a clinical history of
OA or other joint disorders42. This degenerated (DG) carti-
lage, containing increased levels of damaged collagen
molecules, can be considered an early, pre-clinical phase
of OA43. In this study, we have compared within each donor
the post-translational modiÞcations (lysyl hydroxylation and
pyridinoline cross-linking) of collagen as well as the proteo-
glycan content of normal and DG knee cartilage. To ensure
that the collagen network of normal and DG cartilage of a
donor was of the same biological age, pentosidine levels
were measured. Pentosidine is a cross-link resulting from
non-enzymatic glycation. It accumulates linearly with age in
cartilage after the age of 20 years, which is consistent with
the long half-life (around 100200 years) of collagen in
adult cartilage13,14. Pentosidine serves as a suitable
biomarker to estimate the age and the remodeling of the
collagen network13,14,44,45. Knowing the biological age of
the collagen network between normal and DG cartilage of
each donor is of particular importance: if the collagen
network in DG cartilage is of a younger age than that of
normal cartilage, it is difficult to discriminate whether
changes in lysyl hydroxylation and pyridinoline cross-
linking in DG cartilage are of a secondary nature (i.e.
changes due to new collagen synthesis) or a primary event
involved in the degeneration. When the collagen network is
of the same biological age, the extremely slow turnover of
the collagen network after adolescence implies that differ-
ences in post-translational modiÞcations between normal
and DG collagen precede OA pathology by several dec-
ades. Thus, in the latter case, differences in post-
translational modiÞcations may have played a causative
role in the predisposition of the collagen network to fatigue.Materials and methods
CARTILAGE
Normal and degenerated (DG) cartilage were obtained
post mortem at autopsy from weight bearing areas of
human femoral knee condyles within 24 h after death of the
donor. The age of the donors (N=6) was 49, 60, 72, 83, 86
and 92 years. None of the donors had a clinical history of
joint disorders. The cartilage was cut with a scalpel blade,
excluding the underlying bone. DG cartilage, designated by
macroscopic focal Þbrillation of the articular surface, was
obtained from the lateral or medial condyle and represents
a pre-clinical stage of OA43. Normal cartilage, designated
by a glossy, white, completely smooth surface and a
healthy appearance, was obtained from a comparable
position of the contralateral knee from the same donor. All
cartilage cubes were divided in an upper half (the region
near the articular surface) and a lower half (the region
adjacent to the bone). From each donor (N=6) three
normal and three degenerated pieces of cartilage were
obtained. This resulted in 36 cartilage specimens from the
upper part and 36 from the lower part (18 normal and 18
DG specimens).LYSYL HYDROXYLATION AND CROSS-LINKING OF COLLAGEN
Normal and degenerated cartilage pieces (routinely
12 mg dry weight) were hydrolysed (108°C, 2024 h) with
6 M HCl in teßon-sealed glass tubes. The hydrolysed
samples were dried and redissolved in 200 l water con-
taining 10 M pyridoxine (internal standard for the cross-
links) and 2.4 mM homoarginine (internal standard for
amino acids) (Sigma, St Louis, MO). Samples were diluted
5-fold with 0.5% (v/v) heptaßuorobutyric acid (Fluka,
Buchs, Switzerland) in 10% (v/v) acetonitrile for cross-link
analysis; aliquots of the Þve-fold diluted sample were
diluted 50-fold with 0.1 M sodium borate buffer pH 8.0 for
amino acid analysis. Derivatization of the amino acids with
9-ßuorenylmethyl chloroformate and reversed-phase high-
performance liquid chromatography of amino acids
(hydroxyproline, Hyp, hydroxylysine, Hyl, and proline, Pro)
and cross-links (hydroxylysylpyridinoline, HP, lysylpyridino-
line, LP, and pentosidine) were performed on a Micropak
ODS-80TM column (150×4.6 mm; Varian, Sunnyvale,
USA) as described previously46,47. The quantities of cross-
links as well as Hyl were expressed as the number of
residues per collagen molecule, assuming 300 Hyp resi-
dues per triple helix. As acid hydrolysis converts glucosyl-
galactosylhydroxylysine and galactosylhydroxylysine into
hydroxylysine in a stoichiometric way, the data reßect total
hydroxylysine levels. Although it is known that pentosidine
is present in non-collagenous proteins as well, no attempt
was made to correct for this release, as pentosidine in
cartilage hydrolysates predominantly originates from the
collagen network48. No attempt was made to deplete the
proteoglycans from the cartilage, because we were inter-
ested in the amount of proteoglycans in the cartilage as
well. The relative amount of proteoglycans was estimated
by the ratio Hyp/Pro as we reasoned that the lower the
Hyp/Pro ratio the more non-collagenous proteins (mainly
proteoglycans) are present in the tissue. The relationship
between proteoglycan content and Hyp/Pro ratio was
tested by comparing the Þxed charge density (FCD) and
the Hyp/Pro in a separate set of samples.
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The FCD is deÞned as the concentration of Þxed nega-
tively charged groups (chondroitin sulfate and keratan
sulfate) in the tissue (expressed as mmol/g tissue). The
relationship between FCD and Hyp/Pro ratio was deter-
mined in a series of full-depth cartilage plugs derived from
normal human femoral heads obtained post mortem
at autopsy. The FCD was determined as described by
Maroudas and co-workers8. After washing out the radio-
active tracer, the specimens were freeze-dried to constant
weight; subsequently, amino acid analysis was performed
as described above.DATA PRESENTATION
From each donor only samples with comparable (vari-
ation ±10%) pentosidine levels were used to compare the
post-translational modiÞcations of the collagen network and
the Hyp/Pro ratio between DG and normal cartilage. DG
specimens that could not be matched with normal speci-
mens were omitted: they all showed minimally 10% lower
pentosidine levels, indicating the presence of newly synthe-
sized collagen. In the Þgures, each point is the mean of the
replicates derived from one donor; thus, each point repre-
sents the mean of three replicates unless samples had to
be excluded due to low pentosidine levels. Paired two-
sided t-tests were applied to test statistical signiÞcance
between DG and normal cartilage.35
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Fig. 1. Variation in hydroxylysine level of collagen (expressed as number of residues per triple helix) in normal and degenerated cartilage.
Cartilage was divided in an upper half (top: the region near the articular surface) and a lower half (bottom: the region adjacent to the bone).
Lines connect normal and degenerated cartilage from one donor.Results
Chondrocytes in OA cartilage exhibit increased syn-
thesis rates of collagen49. The collagen network in OAcartilage may therefore contain signiÞcant amounts of
newly synthesized collagen. In such event, comparing the
post-translational modiÞcations of collagen of normal and
OA cartilage is severely hampered: it is impossible to
discriminate whether changes in OA are of a secondary
nature (due to newly synthesized collagen in an attempt to
repair the cartilage defect) or a primary event. As we
wanted to compare collagen modiÞcations (lysyl hydroxyl-
ation and pyridinoline cross-linking) in cartilage that
showed no signiÞcant remodeling of the collagen network,
we investigated normal and degenerated femoral condyle
cartilage obtained from donors without a clinical history for
joint diseases. This degenerated cartilage represents a
preclinical stage of OA43 and was expected to contain little
newly synthesized collagen. Indeed, in all six donors DG
cartilage was found that contained negligible amounts of
newly synthesized collagen (as evidenced by pentosidine
levels). Consequently, the collagen network in these carti-
lage specimens is of the same biological age as that of
normal cartilage, i.e. it was laid down at age <20 years.
A paired Students t-test revealed signiÞcantly higher
levels of Hyl in the upper and lower part of DG cartilage
compared to normal cartilage (P<0.005 and <0.001,
respectively; Fig. 1). The Hyl levels in the upper and lower
part of DG cartilage are 12±7% and 8±3% (mean±S.D.)
higher than in normal cartilage, respectively. Furthermore,
a signiÞcantly higher HP level is found in the upper part of
DG cartilage compared to normal cartilage (P<0.05; Fig. 2).
The HP level in the upper part of DG cartilage is 14±11%
higher than in control tissue. In contrast, the HP level of the
collagen molecules in DG cartilage from the lower part is
the same as in normal cartilage (Fig. 2). There were no
signiÞcant differences between DG and normal cartilage
with respect to the amount of LP, neither in the upper, nor in
the lower part (Fig. 3).
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modiÞcations of collagen (lysyl hydroxylation and pyridino-
line cross-linking)13, the values of the six donors can be
pooled despite the considerable age range (4992 years).
The mean±S.D. of the amount of Hyl, HP, and LP per
collagen molecule for the normal upper part (degenerated
upper part) is 38.5±1.4 (43.2±2.2), 1.41±0.15 (1.60±0.13)
and 0.066±0.007 (0.062±0.018), respectively. The
mean±S.D. of the amount of Hyl, HP, and LP per collagen
molecule for the normal lower part (degenerated lower part)
is 44.3±2.1 (48.0±2.7), 1.70±0.15 (1.70±0.17) and
0.056±0.008 (0.054±0.013), respectively. Consistent with
our previous Þndings13, the amount of Hyl and HP in
normal cartilage increased from the articular surface to the
bone, whereas for LP the reverse is seen. The same zonal
variation was found in DG cartilage.
We reasoned that the ratio Hyp/Pro is indicative for the
amount of non-collagenous proteins (such as proteogly-
cans) compared to collagen. Increased proteoglycan levels
should result in increased Pro levels compared to Hyp
(giving rise to lower Hyp/Pro ratios). This was tested in
full-depth cartilage derived from normal femoral heads.
Indeed a strong correlation (r=0.961; P<0.001) was found
between the FCD (mmol/g dry tissue) and the Hyp/Pro ratio
(Fig. 5). The Hyp/Pro ratio in the upper part of normal
(degenerated) cartilage is 0.772±0.077 (0.763±0.067); in
the lower part of normal (degenerated) cartilage it is
0.627±0.064 (0.615±0.062) (Fig. 4). This is consistent with
the observation, that there are more proteoglycans in the
deep zone than in the surface region50. There was no
signiÞcant difference between the Hyp/Pro ratio of normal
and degenerated cartilage (Fig. 4), indicating that in normal
and DG cartilage the amount of proteoglycans compared to
the amount of collagen is the same.HP/triple helix
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Fig. 2. Variation in hydroxylysylpyridinoline (HP) level of collagen (expressed as number of cross-links per triple helix) in normal and
degenerated cartilage. Cartilage was divided in an upper half (top: the region near the articular surface) and a lower half (bottom: the region
adjacent to the bone). Lines connect normal and degenerated cartilage from one donor.Discussion
Because of their high osmotic pressure proteoglycans
are able to swell almost indeÞnitely. The swelling tendency
of proteoglycans is limited by, and hence induces tensile
stresses in, the collagen network2,4,7. The higher the pro-
teoglycan concentration, the higher the tensile stresses in
the collagen network will be. It is conceivable that higher
tensile stresses make collagen more prone to fatigue. In
our samples, the proteoglycan content between DG and
normal cartilage were comparable. It thus seems unlikely
that this phenomenon plays a role in the impairment of the
collagen network of the studied DG cartilage samples. It is
therefore reasonable to assume that the defect is located in
the collagen network itself, the major structural component
of cartilage.
In adult human articular cartilage, the half-life of the
collagen network is in the order of 100200 years14. Over
several decades, pentosidine accumulates in articular col-
lagen13,14. As a result, de novo synthesis of collagen (as
occurs in OA cartilage), will result in decreased amounts of
pentosidine per collagen molecule44,48. Specimens were
selected showing no differences in pentosidine levels
between DG and normal cartilage obtained from the same
donor. In these specimens, comparison of DG and normal
cartilage is not confounded by de novo synthesis of colla-
gen (i.e. the collagen network in DG cartilage reßects the
situation before the onset of Þbrillation). SigniÞcantly more
hydroxylysine residues and HP cross-links were present
per collagen molecule in the upper part of DG cartilage than
in healthy cartilage. In addition, signiÞcantly more hydroxy-
lysine residues per collagen molecule were found in the
lower part of DG cartilage. Since these differences precede
cartilage Þbrillation, lysyl hydroxylation (and probably
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Fig. 3. Variation in lysylpyridinoline (LP) level of collagen (expressed as number of cross-links per triple helix) in normal and degenerated
cartilage. Cartilage was divided in an upper half (top: the region near the articular surface) and a lower half (bottom: the region adjacent
to the bone). Lines connect normal and degenerated cartilage from one donor.pyridinoline cross-linking as well) may be causally involved
in the mechanically-induced cartilage degeneration due to
collagen fatigue. An increased level of damaged collagen
molecules has been found in osteoarthritic and degener-
ated cartilage, the highest concentrations being localized in
the upper part51,52. Indeed, the largest differences in enzy-
matic modiÞcations between degenerated and normal car-
tilage are observed in the upper part. This suggests a direct
causal relation between collagen modiÞcations and mech-
anical fatigue failure seen in pre-clinical OA cartilage.
As noted before, Hyl and HP increase with depth from
the surface in the collagen in articular cartilage13. By
sampling the top half and the bottom half of the tissue, it
could be argued that the differences in Figs 1(a), (b) and
2(a) are explained by loss of the top half of the degenerated
tissue over time. In that case, the deeper tissue is now
sampled as the surface of degenerated cartilage and
compared to the actual surface of healthy cartilage. How-
ever, if this is the case, one would expect to see differences
between degenerated and normal cartilage in LP and
Hyp/Pro ratios as well, as gradients have been found for
LP13 and proteoglycan concentration50. Since this is not
the case (Figs 3 and 4), it is unlikely that in our samples
erosion of the original surface of degenerated cartilage took
place.
Hydroxylation of triple helical lysyl residues (including
the attachment of the glycosides glucose and galactose on
hydroxylysine) seems to play a crucial role in the formation
of a properly functioning collagen network. A decrease in
Hyl levels results in severe alterations of the ECM organ-
ization, e.g. in Ehlers-Danlos type VI syndrome53. A re-
lationship between lysyl overhydroxylation and phenotypic
severity has been found in osteogenesis imperfecta and
osteochondrodysplasias39. In addition, a close relationshiphas been found between the degree of collagen overmodi-
Þcation and the severity of osteopenia54. Eyre et al.22 noted
a lysyl overhydroxylation in early-onset OA cartilage exhib-
iting the Arg519→Cys mutation. Also Kashin-Beck disease,
an endemic, chronic and degenerative osteoarticular disor-
der found in China, is instructive of the role of collagen
modiÞcation in OA. This is an acquired rather than an
inherited disease: selenium deÞciency in the diet and a high
content of fulvic acid are the main causative factors of the
disease55,56. Cartilage of Kashin-Beck patients showed
increased levels of hydroxylysine55. An increase in lysyl
hydroxylation was also seen in selenium-deÞcient mice and
fulvic acid-supplemented mice56.
A failure of the collagen network is the principal postulate
in many mechanical hypotheses of OA. We have recently
argued that accumulation of non-enzymatic glycation prod-
ucts (such as pentosidine) in the collagen network contrib-
ute to the age-related decrease in the resistance of
cartilage to fatigue13,45. Superimposed on these age-
related non-enzymatic modiÞcations, we now provide evi-
dence that the starting quality of the collagen network (as
laid down in the second decade of life) determines the
susceptibility of cartilage to failure as well. The increased
level of the cross-link HP in the upper part of degenerated
cartilage may lead to changes in the physical properties of
cartilage, making the collagen in the top layer more prone
to mechanical breakdown following normal (repetitive)
loading. In addition, lysyl overhydroxylation seems to alter
the Þbrillar structure of the collagen network, resulting in an
impairment of the functional integrity of the extracellular
matrix. Altogether, changes in modiÞcations of the articular
cartilage collagen network (either enzymatic or non-
enzymatic) seem to reduce its quality: the altered Þbrils
132 R. A. Bank et al.: Collagen modifications in OA cartilagemay be less able in the long term to withstand the mech-
anical stresses that articular cartilage endures throughout
human adult life. Interventions aimed at altering the fatigue
properties of the cartilage collagen network are expected to
delay the age of onset of OA, thus enhancing the quality of
life.Hyp/Pro
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Fig. 4. Variation in the Hyp/Pro ratio (indicative for the amount of non-collagenous proteins compared to collagen) in normal and degenerated
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